Trans Genic Inc.
2342----
Trans Genic Inc. (2342)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- PharmaTimes · Apr 13 at 03:34 AM
Transgene completes randomisation in phase 2 trial of tg4050
- Unusual Whales · Apr 9 at 11:05 AM
Availability of Transgene's 2025 Universal Registration Document (URD)
- Japan Corporate News · Apr 3 at 02:09 AM
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
